Clinical Trials Related to Dana-Farber Cancer Institute

Related studies linked through entity extraction aliases.

Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer

Status: COMPLETED
Phase: PHASE2

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Status: COMPLETED
Phase: PHASE1/PHASE2

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Status: COMPLETED
Phase: NA

Intervention For Adolescents and Young Adults (AYAs) With Cancer Risk Syndromes

Status: ACTIVE_NOT_RECRUITING
Phase: NA

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

CIML NK Cell in Head & Neck Cancer

Status: COMPLETED
Phase: PHASE1

Ibrutinib + Venetoclax in Untreated WM

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

GVAX Plus Checkpoint Blockade in Neuroblastoma

Status: TERMINATED
Phase: PHASE1

Cabozantinib and Nivolumab for Carcinoid Tumors

Status: COMPLETED
Phase: PHASE2

Serial MRI Scans During Radiation Therapy

Status: RECRUITING
Phase: NA

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Status: COMPLETED
Phase: PHASE1

Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT

Status: TERMINATED
Phase: PHASE1/PHASE2

Videos for Advance Care Planning in Young Adults

Status: COMPLETED
Phase: NA

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Palbociclib + Ganitumab In Ewing Sarcoma

Status: TERMINATED
Phase: PHASE2

Smart Phone App Intervention In Young Adults With Cancer

Status: COMPLETED
Phase: NA

Abemaciclib + Pembrolizumab In Glioblastoma

Status: WITHDRAWN
Phase: PHASE2

Stereotactic Magnetic Resonance Guided Radiation Therapy

Status: RECRUITING
Phase: NA

LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy

Status: COMPLETED
Phase: PHASE1